BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/8/2017 3:24:00 PM | Browse: 1021 | Download: 1081
|
Received |
|
2016-07-28 13:49 |
|
Peer-Review Started |
|
2016-07-30 18:08 |
|
To Make the First Decision |
|
2016-09-02 14:26 |
|
Return for Revision |
|
2016-09-08 10:37 |
|
Revised |
|
2016-09-20 11:49 |
|
Second Decision |
|
2016-12-14 18:43 |
|
Accepted by Journal Editor-in-Chief |
|
2016-12-15 00:07 |
|
Accepted by Executive Editor-in-Chief |
|
2016-12-28 15:31 |
|
Articles in Press |
|
2016-12-28 15:31 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2017-01-17 16:51 |
|
Publish the Manuscript Online |
|
2017-02-08 15:32 |
ISSN |
2218-4333 (online) |
Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
|
Copyright |
© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
|
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Oncology |
Manuscript Type |
Review |
Article Title |
Therapeutic management options for stage III non-small cell lung cancer
|
Manuscript Source |
Invited Manuscript |
All Author List |
Stephanie M Yoon, Talha Shaikh and Mark Hallman |
Funding Agency and Grant Number |
|
Corresponding Author |
Talha Shaikh, MD, Department of Radiation Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111,
United States. talha.shaikh@fccc.edu
|
Key Words |
Non-small cell lung cancer; Chemoradiotherapy; Multi-modality; Targeted therapy; Dose-escalation |
Core Tip |
Locally advanced non-small cell lung cancer consists of a heterogeneous population making manage-ment challenging. Multiple strategies are being deve-loped to maximize survival and disease control. The role of surgery is being re-evaluated given new insight into the efficacy chemotherapy and radiation. Multi-modality therapy is playing an increasingly important role for both resectable and unresectable stage III patients. Chemoradiation plays a large role in the management of inoperable or unresectable patients. Third generation chemotherapy and other targeted therapies are being incorporated into chemoradiation. Radiation dose-escalation, alternative fractionation schedules, intensity-modulated radiotherapy, and proton therapy are evaluated to improve outcomes from chemoradiation.
|
Publish Date |
2017-02-08 15:32 |
Citation |
Yoon SM, Shaikh T, Hallman M. Therapeutic management options for stage III non-small cell lung cancer. World J Clin Oncol 2017; 8(1): 1-20 |
URL |
http://www.wjgnet.com/2218-4333/full/v8/i1/1.htm |
DOI |
http://dx.doi.org/10.5306/wjco.v8.i1.1 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345